World Cassava Sciences soars over 200% to 10-year high on positive Alzheimer's treatment data
Surfer saves multiple people from drowning in two separate rescues
A surfer has rescued three children and a father from drowning in two separate incidents less than 24 hours apart off the Victorian coast.A surfer has saved the lives of three children and a father from drowing in two separate incidents in Victoria.
- Shares of Cassava Sciences soared over 200% Tuesday after the company announced positive data on its leading drug candidate for the treatment of Alzheimer's disease.
- The stock price of Cassava Sciences surged toward an almost 10-year high, on track to close at its highest level since June 2011.
- , the drug candidate, improved the cognition and behaviour of patients following six months of treatment.
Shares ofsoared as much as 221% Tuesday after the biopharmaceutical company announced upbeat data on its leading drug candidate for the treatment of Alzheimer's disease.
Christopher Biggins plans to hold huge wake for Dame Barbara Windsor
The comedian, 72, told how they ordinarily would have been able to 'fill Wembley Stadium' with mourners attending a wake for the Carry On star. EastEnders icon Barbara died aged 83 on December 10 last year after being diagnosed with Alzheimer's disease. © Provided by Daily Mail Long-term friends: Dame Barbara Windsor's close friend Christopher Biggins has revealed plans to hold a huge wake for the late star once the pandemic is over Discussing her funeral, which was attended by 29 people, Christopher revealed plans to host a bigger celebration of Barbara's life in the future.
The stock price of the Austin, Texas-based company surged toward an almost 10-year high, on track to close to its highest level since June 2011.
The company released the results of an interim analysis from an open-label study of, its lead drug candidate for the treatment of Alzheimer's disease. Cassava Sciences in a statement said the cognition and behaviour scores of its patients following six months of simufilam treatment improved.
"An improvement in cognition and behaviour tells us this drug candidate has potential to provide lasting treatment effects for people living with Alzheimer's disease," said Remi Barbier, President & CEO. "It's an exciting development."
More than five million Americans are living with the disease, according to the.
The clinical study, which started in March 2020, is an on-going, one-year, open-label, multi-centre study evaluating the long-term safety and tolerability of simufilam in 100 patients with mild-to-moderate Alzheimer's disease. The study was funded by the National Institutes of Health.
Shares of Cassava Sciences $US60.34 as of 2:51PM E.T. on Tuesday.
Singer Engelbert Humperdinck's wife Patricia Healey dies days after contracting coronavirus amid Alzheimer's battle .
Actress Patricia Healey, the wife of music icon Engelbert Humperdinck, has died aged 85. The British singer shared the sad news on Facebook and Instagram over the weekend, announcing Healey passed away days after the couple revealed they had contracted COVID-19. Healey was also battling Alzheimer's disease at the time of her death. "Our family is heartbroken over the loss of my darling wife," wrote Humperdinck, 84. "Last night, she slippedThe British singer shared the sad news on Facebook and Instagram over the weekend, announcing Healey passed away days after the couple revealed they had contracted COVID-19. Healey was also battling Alzheimer's disease at the time of her death.